Table of Contents: Oncotarget Volume 12, Issue #11

Listen to the latest oncology-focused research published in this week’s issue of Oncotarget, Volume 12, Issue 11. View the complete issue: https://www.oncotarget.com/archive/v12/i11/ COVER PAPER: “CEA as a blood-based biomarker in anal cancer” https://doi.org/10.18632/oncotarget.27959 NEWS: “FGFR1, a novel biomarker for metastatic castration-resistant prostate cancer?” https://doi.org/10.18632/oncotarget.27957 (PDF Download) EDITORIAL: “Advances in innovative exosome-technology for real time monitoring of viable drugs in clinical translation, prognosis and treatment response” https://doi.org/10.18632/oncotarget.27927 (PDF Download) EDITORIAL: “Drug-development, dose-selection, rational combinations from bench-to-bedside: are there any lessons worth revisiting?” https://doi.org/10.18632/oncotarget.27931 (PDF Download) RESEARCH PAPER: “Occurence of RAS reversion in metastatic colorectal cancer patients treated with bevacizumab” https://doi.org/10.18632/oncotarget.27965 RESEARCH PAPER: “Caspase-11 and AIM2 inflammasome are involved in smoking-induced COPD and lung adenocarcinoma” https://doi.org/10.18632/oncotarget.27964 RESEARCH PAPER: “A novel E2F1-regulated lncRNA, LAPAS1, is required for S phase progression and cell proliferation” https://doi.org/10.18632/oncotarget.27962 RESEARCH PAPER: “Epigallocatechin-3-gallate modulates Tau Post-translational modifications and cytoskeletal network” https://doi.org/10.18632/oncotarget.27963 RESEARCH PAPER: “Ex vivo analysis of DNA repair targeting in extreme rare cutaneous apocrine sweat gland carcinoma” https://doi.org/10.18632/oncotarget.27961 REVIEW: “Evaluation of liver kinase B1 downstream signaling expression in various breast cancers and relapse free survival after systemic chemotherapy treatment” https://doi.org/10.18632/oncotarget.27929 CASE REPORT: “Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review” https://doi.org/10.18632/oncotarget.27966 Keywords - anal cancer, prostate cancer, colorectal cancer, lung cancer, breast cancer, exosomes, cell proliferation, Tau protein, Alzheimer’s disease, DNA repair, advanced squamous cell carcinoma, cancer, science, research, oncology About Oncotarget Oncotarget is a bi-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology. To learn more about Oncotarget, please visit https://www.oncotarget.com/ or connect with: SoundCloud - https://soundcloud.com/oncotarget Facebook - https://www.facebook.com/Oncotarget/ Twitter - https://twitter.com/oncotarget LinkedIn - https://www.linkedin.com/company/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/oncotargetyoutube Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget Oncotarget is published by Impact Journals, LLC. Please visit https://www.impactjournals.com/ or connect with @ImpactJrnls Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957